The OCMX™ is pleased to announce the listing of OraVu to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

SCOTTSDALE, AZ, April 27, 2020 /Neptune100/ — Oral health has a significant impact on systemic health as patients with poor oral hygiene cost the US more than $4B annually in general health expenses.

Poor oral care leads to periodontal disease, with roughly 3M new diagnoses annually in the US alone. With aging populations in much of the developed world, more effective, efficient, patient-friendly treatments are needed.

Today’s front-line treatment, “deep cleaning” (Scaling and Root Planing) is done strictly by feel, leaving up to 40% of the dangerous buildup behind. More severe cases can require gingival flap surgery, which is expensive and painful, with 2 weeks’ recovery time.

OraVu’s DeVA-1® allows clinicians to see below the gumline without surgery, so they’re no longer working blind and no longer have to perform surgery to clean teeth.

Performed by the hygienist, “Visual-Scaling and Root Planing” (VSRP) with a micro-endoscope provides comparable results to gingival flap surgery at a fraction of the cost for both the patient and the provider.

You can see the difference here:

The OCMX™ is pleased to announce the listing of OraVu to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

The OCMX™ has spent considerable time completing its due diligence on OraVu and concluded that there is indeed a tremendous opportunity for Investors and Advisors.

The OCMX™ noted that OraVu exhibits the main components of any solid investment opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.


1. Aging worldwide population
As global populations age and overall healthcare spending must be controlled, demand for preventative solutions like OraVu’s will increase. We believe this will be particularly prevalent in regions with single payer / centralized healthcare systems, as well as those with lower access to dental care. China presents an exciting opportunity in this area, as does Europe.

2. Low percentage of non-surgical treatment for periodontal disease
Current options for treatment need to be repeated (blind SRP) or are expensive and painful (gingival flap surgery) – meaning that a more attractive option for patients will increase treatment adoption and provider revenues.

3. Competitive pressures in the general dentistry market
General dentists are seeking additional procedures for patient retention & revenue boosting. By offering procedures that are more effective and less painful than others, more patients will accept the prescribed treatment (VSRP) instead of allowing their condition to go untreated. This helps the patient avoid tooth loss and (eventually) implants, while generating additional revenue for the dentist.

4. Growing research demonstrating linkage between oral health and major system disorders
Research continues to identify links between oral hygiene and systemic health, with poor oral health being linked to major conditions like Alzheimers, stroke, diabetes, cancer, and others. As these links are better understood and publicized, we expect the demand for preventative solutions like OraVu’s to increase. In light of the wealth of information publicly available, we believe this will also lead more patients to request VSRP treatment, creating an additional marketing path to doctors who may not be familiar with VSRP and OraVu. We anticipate expansion of treatment codes to improve reimbursement of VSRP procedures, growing revenue opportunities and barriers to entry.

5. Capital efficiency
OraVu uses contract manufacturing to keep manufacturing costs reasonable and inventory low. The company has also negotiated agreements with two finance companies which provide for quasi-immediate reception of client payments. These two decisions allow OraVu to efficiently use its capital.


Michael D. Austin, CEO

Michael Austin has held key leadership roles in manufacturing and distribution companies in small business and Fortune 500 environments. He also has broad industry experience ranging from sports medical products, lightning location and data distribution, aerospace and automotive. Products he has engineered and designed include safety of flight components for military and commercial aircraft and the space shuttle.

He transitioned an innovative and unique sports medical product from prototype to production and its entry into the marketplace resulting in injury prevention for thousands of athletes. His leadership roles have included GM, VP, President, COO and CEO responsibilities in challenging business environments involving business turnaround, start-ups and rapid profitable growth. He is the author of “Motivational Model for Sales Engineers” and has served on the board of directors for domestic and foreign companies, including Météorage of Pau, France; Restorative Biosciences of Scottsdale and Rowpar Pharmaceutical.

Michael holds a Master’s degree in Management from the University of Redlands and Engineering degree from Northrop University.

Diane Hammond, Director of Sales & Marketing

Diane is a dedicated professional who is enthusiastic, forward thinking and strategically adept. During the first years of her career, she started as an dental assistant and later entered into the dental cooperate world as a skilled asset in pharmaceuticals, medical devices, sales, marketing and management for several dental companies in AZ.

She has an innate ability to multi-task and her excellent dental knowledge and expertise is clearly evident in all she does. She is committed to working hard to achieve success for her team and for the organization.

Albert Tian, Director of Operations & Technology

Mr. Tian has led an impressive career in his experience in the medical device industry. Serving as the Director of Operations and Technology at OraVu, Haopeng Tian plays a major role in operations management, technology research & development, supply chain management, and customer support. Through his commitment to this role, he has helped OraVu overcome technology obstacles, launch new product, and coordinate with overseas distributor.

Haopeng is a polyglot who proficient in English, Mandarin, Cantonese and Japanese. He is skilled in Data Structure, Probability Analysis, Supply Chain management, Quantitive Analytics, and Optimization Analysis.

Strong technology and business development professional with double majors in Bachelor of Science, BS – focused in Management Science and Math-Computer Science from University of California San Diego.


The OCMX™ is literally changing how companies and investment funds generate exposure in the marketplace and raise funds as we know it. The OCMX™ serves both public and private companies along with investment and mutual funds which need to raise additional funds or gain significant market exposure. It does this by way of connecting the relevant companies, funds, investors, and advisors all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.

The OCMX™ connects investors and advisors directly with companies and investment funds seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]